The EU-Joint Action Antimicrobial Resistance and Healthcare-Associated Infections  (EU-JAMRAI) aims to foster synergies among the EU Member States by developing and implementing effective One Health policies to fight the rising threat of AMR and to reduce HCAI.

The Layman Report contains a full overview of the main outcomes and results of the EU-JAMRAI. Brought together from results by the EU-JAMRAI partners spanning 3,5 years (September 2017 – February 2021) the Layman report is a brief and visual document to inform decision-makers and non-technical parties of the EU-JAMRAI results and recommendations.